Our Mandate Is Simple...
To help and educate people so that they can regain
their health and achieve their fitness goals 7 minutes at a time..
Saturday, November 21, 2015
Bluebird Bio's Best Bet Is To Tackle Sickle Cell Disease
Bluebird Bio (BLUE) has had a bad year with beta-thalassemia, and the stock hasn’t done well as a result. Nonetheless, the Cambridge, Mass.-based company's most important measure is how well it does with sickle cell disease, or SCD, which is a much larger market.